HK1128937A1 - Transcription infidelity, detection and uses thereof - Google Patents

Transcription infidelity, detection and uses thereof

Info

Publication number
HK1128937A1
HK1128937A1 HK09105086.5A HK09105086A HK1128937A1 HK 1128937 A1 HK1128937 A1 HK 1128937A1 HK 09105086 A HK09105086 A HK 09105086A HK 1128937 A1 HK1128937 A1 HK 1128937A1
Authority
HK
Hong Kong
Prior art keywords
infidelity
detection
transcription infidelity
design
disease
Prior art date
Application number
HK09105086.5A
Other languages
English (en)
Inventor
Bernard Bihain
Original Assignee
Transmedi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transmedi Sa filed Critical Transmedi Sa
Publication of HK1128937A1 publication Critical patent/HK1128937A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6827Hybridisation assays for detection of mutation or polymorphism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Glass Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pit Excavations, Shoring, Fill Or Stabilisation Of Slopes (AREA)
  • Peptides Or Proteins (AREA)
HK09105086.5A 2006-07-20 2009-06-08 Transcription infidelity, detection and uses thereof HK1128937A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06291176A EP1887088A1 (en) 2006-07-20 2006-07-20 Transcription infidelity, detection and uses thereof
PCT/EP2007/057541 WO2008009751A2 (en) 2006-07-20 2007-07-20 Transcription infidelity, detection and uses thereof

Publications (1)

Publication Number Publication Date
HK1128937A1 true HK1128937A1 (en) 2009-11-13

Family

ID=37496681

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09105086.5A HK1128937A1 (en) 2006-07-20 2009-06-08 Transcription infidelity, detection and uses thereof

Country Status (19)

Country Link
US (1) US8288091B2 (xx)
EP (3) EP1887088A1 (xx)
JP (1) JP5298013B2 (xx)
KR (1) KR101502179B1 (xx)
AT (1) ATE524565T1 (xx)
AU (1) AU2007275068B2 (xx)
BR (1) BRPI0714563B8 (xx)
CA (1) CA2658305C (xx)
CY (2) CY1112125T1 (xx)
DK (2) DK2468885T3 (xx)
ES (2) ES2373428T3 (xx)
HK (1) HK1128937A1 (xx)
HU (1) HUE028135T2 (xx)
IL (1) IL196600A0 (xx)
PL (2) PL2468885T3 (xx)
PT (2) PT2046986E (xx)
SI (2) SI2046986T1 (xx)
TR (1) TR201112295Y (xx)
WO (1) WO2008009751A2 (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2071334A1 (en) * 2007-12-14 2009-06-17 Transmedi SA Compositions and methods of detecting TIABS
EP2080812A1 (en) 2008-01-18 2009-07-22 Transmedi SA Compositions and methods of detecting post-stop peptides
EP2995688A1 (en) 2014-09-12 2016-03-16 Genclis Methods of prognosing and treating triple negative breast cancer
WO2017100789A1 (en) * 2015-12-11 2017-06-15 Expression Pathology, Inc. Srm/mrm assays
CA3018114A1 (en) 2016-03-18 2017-09-21 Genclis Molecular origin of allergy
WO2018187216A1 (en) * 2017-04-03 2018-10-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Expression cassettes and methods for detecting transcription errors
EP3939047A4 (en) 2019-03-10 2022-11-30 Ultima Genomics, Inc. METHODS AND SYSTEMS FOR SEQUENCE CALLING
KR20220044212A (ko) 2019-08-09 2022-04-06 넛크래커 테라퓨틱스 인코포레이티드 미세유체 장치 및 이의 사용 방법
KR102334576B1 (ko) * 2019-08-12 2021-12-07 한국생명공학연구원 융합 단백질 및 이를 포함하는 바이오 이미징용 조성물
US20230343416A1 (en) * 2020-09-10 2023-10-26 Ultima Genomics, Inc. Methods and systems for sequence and variant calling
EP4162948A1 (en) 2021-10-05 2023-04-12 Genclis Transcription infidelity derived chimeric immunogens and uses thereof
WO2023104904A2 (en) 2021-12-08 2023-06-15 Genclis The sars-cov-2 and variants use two independent cell receptors to replicate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4979330A (en) 1989-10-10 1990-12-25 Rorant Julius W Suction insect trap device
US6120992A (en) 1993-11-04 2000-09-19 Valigene Corporation Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification in a diseased human
AU2715601A (en) * 1999-12-03 2001-06-12 Koninklijke Nederlandse Akademie Van Wetenschappen Clearance of aberrant protein in correlation with disease
CA2439098A1 (en) 2001-02-21 2002-10-03 Gene Check, Inc. Mutation detection using muts and reca
WO2006053061A2 (en) * 2004-11-10 2006-05-18 Kansas State University Research Foundation Porcine reproductive and respiratory syndrome virus receptor components and uses thereof

Also Published As

Publication number Publication date
DK2046986T3 (da) 2012-01-02
HUE028135T2 (en) 2016-12-28
EP2468885A3 (en) 2012-08-29
BRPI0714563B8 (pt) 2021-05-25
SI2046986T1 (sl) 2012-05-31
US20090317386A1 (en) 2009-12-24
PT2468885E (pt) 2015-11-26
CA2658305C (en) 2017-07-18
CY1116939T1 (el) 2017-04-05
DK2468885T3 (da) 2016-02-29
WO2008009751A3 (en) 2008-07-31
CY1112125T1 (el) 2015-11-04
CA2658305A1 (en) 2008-01-24
US8288091B2 (en) 2012-10-16
EP2046986B1 (en) 2011-09-14
PT2046986E (pt) 2011-12-29
BRPI0714563A2 (pt) 2015-04-14
SI2468885T1 (sl) 2016-02-29
EP2046986A2 (en) 2009-04-15
BRPI0714563B1 (pt) 2019-07-02
WO2008009751A2 (en) 2008-01-24
EP1887088A1 (en) 2008-02-13
TR201112295Y (tr) 2018-08-27
ATE524565T1 (de) 2011-09-15
AU2007275068B2 (en) 2013-06-06
IL196600A0 (en) 2009-11-18
EP2468885A2 (en) 2012-06-27
PL2046986T3 (pl) 2012-02-29
JP2009544284A (ja) 2009-12-17
ES2373428T3 (es) 2012-02-03
PL2468885T3 (pl) 2016-04-29
KR101502179B1 (ko) 2015-03-12
AU2007275068A1 (en) 2008-01-24
KR20090052861A (ko) 2009-05-26
ES2553435T3 (es) 2015-12-09
JP5298013B2 (ja) 2013-09-25
EP2468885B1 (en) 2015-08-19

Similar Documents

Publication Publication Date Title
HK1128937A1 (en) Transcription infidelity, detection and uses thereof
WO2007098070A3 (en) Non-invasive methods for evaluating retinal affecting neurodegenerative diseases
WO2005103281A3 (en) Platelet biomarkers for the detection of disease
WO2009085234A3 (en) Use of micro-rna as a biomarker of immunomodulatory drug activity
DK1991697T3 (da) DNA-konformation (LOOP-strukturer) ved normal og anormal genekspression
MX2009007368A (es) Deteccion, tratamiento y monitoreo de la inflamacion, por medio del receptor de disparo expresado en la celula 1 mieloide (trem-1).
WO2006073682A3 (en) Diagnostic test
HRP20130618T1 (xx) POSTUPAK UPORABE miRNA ZA DETEKCIJU IN VIVO SMRTI STANICE
GB2463401B (en) Characterizing prostate disorders by analysis of microvesicles
WO2009102895A3 (en) Method to predict response to pharmacological chaperone treatment of diseases
WO2010054386A3 (en) Methods, compositions, and devices utilizing microrna to determine physiological conditions
EP2020910A4 (en) METHOD AND APPARATUS FOR RECOGNIZING ABNORMAL TISSUE BY DETECTING EARLY INCREASE IN MICROVASCULAR BLOOD IRRIGATION
WO2012142301A3 (en) Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury
WO2012142300A3 (en) Methods of determining a treatment protocol for and/or a prognosis of a patient's recovery from a brain injury resulting from a hypoxic event
WO2005089310A3 (en) Breath test for oral malodor
WO2006074450A3 (en) Methods and compositions for detecting and modulating periodontal disorders and periodontal diseases
WO2012006056A3 (en) Ccr6 as a biomarker of alzheimer's disease
WO2007110623A3 (en) Screening method
WO2007067719A3 (en) Diagnosing human diseases by detecting dna methylation changes
WO2010105235A3 (en) Methods of identification, assessment, prevention and therapy of lung diseases and kits thereof including gender-based disease identification, assessment, prevention and therapy
WO2008012692A3 (en) Assay for efficacy of histone deacetylase inhibitors
WO2009087689A3 (en) Novel primers for identification of astrocytoma, it's grades and glioblastoma prognosis
WO2006097462A3 (en) Compositions and methods for treating inflammatory cns disorders
WO2012098542A3 (en) Methods and kits for assessing heparanase procoagulant activity, compositions comprising heparanase, and methods for the treatment of coagulation-related disorders
WO2009143512A3 (en) Compositions and methods relating to detection of soluble e-cadherin in neurodegenerative disease